Black Market Retatrutide Linked to Multiple Deaths
"It is concerning because of the breakdown of our drug-approval process in the United States of America." The post Black Market Retatrutide Linked to Multiple Deaths appeared first on Futurism .
A deadly black market trade in an experimental weight loss drug called retatrutide is now drawing the attention of the Food and Drug Administration (FDA). According to CBS, the FDA has received at least two reports of deaths linked to the unapproved drug, marking the first public acknowledgment that the knockoffs contributed to users' demise.
The details, while unverified, suggest the black market retatrutide played a role in the deaths, though it may have been a complicating factor. In one instance, a 41-year-old woman died after using the drug, which she obtained from an unreliable source, and suffered a cardiac arrest. Though further investigation is needed, the FDA's involvement indicates concern over the illicit retatrutide trade.
The drug, developed by Eli Lilly, had not completed clinical trials or been released by a licensed manufacturer when it entered the black market. Despite this, the FDA has received reports of serious side effects from the drug, including kidney injury, extreme dehydration, and prolonged diarrhea. Associate Professor Pieter Cohen of Harvard Medical School notes the situation is troubling due to the breakdown of the U.S. drug-approval process.
Written by urgent.news from Futurism's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.